Bids Are Invited For Acquisition Of Standardized Medicines Without Current Pr.

Levonorgestrel - Active Ingredient: Levonorgestrel; Concentration/Dosage: 0.75 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Carboplatin - Active Ingredient: Carboplatin; Concentration/Dosage: 450 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Vial-Ampule; Compone, Cyclophosphamide - Active Ingredient: Cyclophosphamide; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Coated Extended Release Tablet; Aprese, Vincristine - Active Ingredient: Vincristine, Sulfate; Concentration/Dosage: 1 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule Bottle, Zoledronic Acid - Active Ingredient: Zoledronic Acid; Concentration/Dosage: 4 Mg; Pharmaceutical Form: Lyophilized Powder Or Injectable Solution; Presentation, Desferoxamine - Active Ingredient: Desferoxamine, Mesylate; Concentration/Dosage: 500 Mg; Pharmaceutical Form: Injectable Lyophilized Powder; Presentation: F, Carbachol - Active Ingredient: Carbachol, Chloride; Concentration/Dosage: 0.1 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 2 Ml Ampoule Bottle, Solution For Peritoneal Dialysis - Active Ingredient: Glucose + Associations; Concentration/Dosage: 15 Mg/Ml (1.5%) Glucose; Pharmaceutical Form: Solution, Insulin - Active Ingredient: Recombinant Nph Human Insulin; Concentration/Dosage: 100 Iu/Ml; Pharmaceutical Form: Injectable Suspension; Presentation: F, Salbutamol, Sulfate - Active Ingredient: Salbutamol, Sulfate; Concentration/Dosage: 0.5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampol, Metaraminol - Active Ingredient: Metaraminol, Hemitartrate; Concentration/Dosage: 10 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule, Rifampicin - Active Ingredient: Rifampicin; Concentration/Dosage: 300 Mg; Pharmaceutical Form: Hard Gelatin Capsule; Presentation: .; Component: .;, Ephedrine - Active Ingredient: Ephedrine, Sulfate; Concentration/Dosage: 50 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule; Compon, Neostigmine - Active Ingredient: Neostigmine, Methylsulfate; Concentration/Dosage: 0.5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule, Vitamin And/Or Mineral Supplement - Composition (1): A + B1 + B2 + B3 + B5 + B6+ B8 + C + D + E; Composition (2): .; Pharmaceutical Form: Oral Solution; A, Suxamethonium Chloride - Active Ingredient: Suxamethonium Chloride; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Powder For Injectable Solution; Intro, Nimodipine - Active Ingredient: Nimodipine; Concentration/Dosage: 30 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Atropine - Active Ingredient: Atropine, Sulfate; Concentration/Dosage: 10 Mg/Ml (1%); Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle; C, Iodized Poppy Oil - Active Ingredient: Iodized Poppy Oil; Concentration/Dosage: 480 Mg/Ml Iodine; Pharmaceutical Form: Injectable Solution; Apres, Calcium Polystyrenesulfonate Active Ingredient: Calcium Polystyrenesulfonate; Concentration/Dosage: 900 Mg/G; Pharmaceutical Form: Powder For Suspension, Cholestyramine - Active Ingredient: Cholestyramine; Concentration/Dosage: 854.4 Mg/G; Equivalence: 4.0 G Anhydrous Cholestyramine; Pharmaceutical Form: Powder P, Pamidronic Acid - Active Ingredient: Pamidronic Acid; Concentration/Dosage: 90 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Apresen, Oxacillin - Active Ingredient: Oxacillin Sodium; Concentration/Dosage: 500 Mg; Pharmaceutical Form: Powder For Injectable Solution; Presentation: Bottle